Kronox Lab Sciences Ltd Asset Resilience Ratio

Latest as of March 2026: 36.07%

Kronox Lab Sciences Ltd asset resilience ratio. Kronox Lab Sciences Ltd (KRONOX) has an Asset Resilience Ratio of 36.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kronox Lab Sciences Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs459.95 Million
≈ $4.97 Million USD Cash + Short-term Investments

Total Assets

Rs1.28 Billion
≈ $13.79 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of Kronox Lab Sciences Ltd (2022–2026)

Asset resilience ratio of Kronox Lab Sciences Ltd from 2022 to 2026. This chart shows how Kronox Lab Sciences Ltd's Asset Resilience Ratio has changed over time. Read KRONOX total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Kronox Lab Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Kronox Lab Sciences Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs459.95 Million 36.07%
Total Liquid Assets Rs459.95 Million 36.07%

Asset Resilience Insights

  • Very High Liquidity: Kronox Lab Sciences Ltd maintains exceptional liquid asset reserves at 36.07% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Kronox Lab Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare Kronox Lab Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hengyi Petrochemical Co Ltd
SHE:000703
Specialty Chemicals 0.06%
Akzo Nobel NV
AS:AKZA
Specialty Chemicals 2.16%
LB Group Co Ltd
SHE:002601
Specialty Chemicals 4.81%
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390
Specialty Chemicals 0.39%
Cngr Advanced Material Co Ltd
SHE:300919
Specialty Chemicals 0.52%
Qingdao Gon Technology Co Ltd
SHE:002768
Specialty Chemicals 0.01%
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240
Specialty Chemicals 0.00%
Borregaard ASA
OL:BRG
Specialty Chemicals 0.98%

Kronox Lab Sciences Ltd Asset Resilience Ratio by Year (2022–2026)

Kronox Lab Sciences Ltd asset resilience ratio by year from 2022 to 2026. The table below shows the annual Asset Resilience Ratio data for Kronox Lab Sciences Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 36.07% Rs459.95 Million
≈ $4.97 Million
Rs1.28 Billion
≈ $13.79 Million
+2.84pp
2025-03-31 33.23% Rs328.38 Million
≈ $3.55 Million
Rs988.26 Million
≈ $10.69 Million
+16.56pp
2024-03-31 16.66% Rs123.31 Million
≈ $1.33 Million
Rs739.94 Million
≈ $8.00 Million
+10.81pp
2023-03-31 5.86% Rs31.64 Million
≈ $342.17K
Rs540.34 Million
≈ $5.84 Million
-11.26pp
2022-03-31 17.11% Rs97.18 Million
≈ $1.05 Million
Rs567.88 Million
≈ $6.14 Million
--
pp = percentage points

About Kronox Lab Sciences Ltd

NSE:KRONOX India Specialty Chemicals
Market Cap
$79.33 Million
Rs7.34 Billion INR
Market Cap Rank
#19908 Global
#1087 in India
Share Price
Rs197.70
Change (1 day)
+1.71%
52-Week Range
Rs97.02 - Rs218.79
All Time High
Rs221.37
About

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health;… Read more